Tumor-related mutations in cell-free DNA in pre-operative plasma as a prognostic indicator of recurrence in endometrial cancer.
Daisuke ShintaniTaro HiharaAiko OgasawaraSho SatoAkira YabunoKenji TaiKeiichi FujiwaraKeisuke WatanabeKosei HasegawaPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)
Tumor-related ctDNA detected in plasma before surgery was associated with poorer oncologic outcome on univariate analysis in patients with endometrial cancer harboring PIK3CA or KRAS mutations.